scholarly journals Practical implementation of noninvasive ventilation in Amyotrophic Lateral Sclerosis: lessons learned from a clinical case series

2019 ◽  
Vol 55 ◽  
pp. 13-15
Author(s):  
Elizabeth Parsons ◽  
John Carter ◽  
Joanna Wrede ◽  
Lucas Donovan ◽  
Brian Palen
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Noninvasive Ventilation ◽  
Clinical Case ◽  
Case Series ◽  
Lessons Learned ◽  
Practical Implementation ◽  
Lateral Sclerosis

Factors Influencing Noninvasive Ventilation Initiation in Amyotrophic Lateral Sclerosis

CHEST Journal ◽  
2017 ◽  
Vol 152 (4) ◽  
pp. A187
Author(s):  
Pradeep Doddamreddy ◽  
Gaurav Singh ◽  
Brittany Schultz ◽  
Michelle Cao
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Noninvasive Ventilation ◽  
Factors Influencing ◽  
Lateral Sclerosis

scholarly journals CLINICAL CASE OF MANAGING A PATIENT WITH DIAGNOSIS AMYOTROPHIC LATERAL SCLEROSIS

2019 ◽  
Vol 20 (2) ◽  
pp. 290-292
Author(s):  
Anvarkhon Amirovich Inomov ◽  
◽  
Evginii Lavrentevich Ivanov ◽  
Nadirbek Alimsoltanovich Dydymov
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Clinical Case ◽  
Lateral Sclerosis

scholarly journals Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report

2021 ◽  
pp. 026921632110453
Author(s):  
Kelvin Lou ◽  
Shane Murphy ◽  
Clair Talbot
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Side Effects ◽  
Lessons Learned ◽  
Case Presentation ◽  
Course Of Action ◽  
Research Problems ◽  
Neuropathic Pruritus ◽  
Gastrointestinal Side Effects ◽  
Chronic Pruritus ◽  
Lateral Sclerosis

Background: Neuropathic symptoms have a wide variety of manifestations, ranging from pain to pruritus. Neuropathic pruritus is a type of chronic pruritus related to damaged small fibers. Cannabinoids have evidence to manage neuropathic symptoms. We present a case of refractory neuropathic pruritus that was successfully managed with the use of oral cannabinoids. Case presentation: A 60-year-old male with amyotrophic lateral sclerosis with ongoing pruritus despite the use of standard neuropathic therapies. Possible course of action: Sodium channel and N-methyl-D-aspartate receptor antagonists have evidence for neuropathic symptoms but can cause significant gastrointestinal side effects. Prescription cannabinoids such as nabiximol can be cost prohibitive to use in practice. Synthetic tetrahydrocannabinol products are dose limited by psychoactive side effects. Formulation of a plan: A balanced oral cannabinoid from a licensed producer was preferred as it has evidence for neuropathic symptoms and is generally well tolerated. Outcome: The patient showed improvement to his pruritus score from 7/10 to 3/10. There was initial increased sedation but tolerance developed quickly. Lessons learned from case: Cannabinoids are possibly safe and effective in management of neuropathic pruritus. View on research problems: Additional research is needed to establish efficacy and safety.

Sign in / Sign up

Export Citation Format

Share Document